Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H10O2 |
| Molecular Weight | 102.1317 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)C(O)=O
InChI
InChIKey=IUGYQRQAERSCNH-UHFFFAOYSA-N
InChI=1S/C5H10O2/c1-5(2,3)4(6)7/h1-3H3,(H,6,7)
| Molecular Formula | C5H10O2 |
| Molecular Weight | 102.1317 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The P2Y(1) and P2Y(12) receptors mediate autoinhibition of transmitter release in sympathetic innervated tissues. | 2009-12 |
|
| Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2. | 2009-08-14 |
|
| Tridecanuclear [Mn(III)5Ln(III)8] complexes derived from N-(t)butyl-diethanolamine: synthesis, structures, and magnetic properties. | 2009-07-20 |
|
| Effect of MK-886 on Ca2+ level and viability in PC3 human prostate cancer cells. | 2009-06 |
|
| Family of heterometallic semicircular Mn(III)2Ln(III)3 strands. | 2009-04-20 |
|
| Establishment of broadly applicable reaction conditions for the palladium-catalyzed direct arylation of heteroatom-containing aromatic compounds. | 2009-03-06 |
|
| C-H bonds as ubiquitous functionality: a general approach to complex arylated pyrazoles via sequential regioselective C-arylation and N-alkylation enabled by SEM-group transposition. | 2009-03-04 |
|
| Tetra-, tri-, and mononuclear manganese(II/III) complexes of a phenol-based N2O2 capping ligand: use of carboxylates as ancillary ligands in tuning the nuclearity of the complexes. | 2009-03-02 |
|
| Development of selective agonists and antagonists of P2Y receptors. | 2009-03 |
|
| Children's toxicology from bench to bed--Liver injury (1): Drug-induced metabolic disturbance--toxicity of 5-FU for pyrimidine metabolic disorders and pivalic acid for carnitine metabolism. | 2009 |
|
| C(aryl)-O activation of aryl carboxylates in nickel-catalyzed biaryl syntheses. | 2009 |
|
| Phosphine-free, palladium-catalyzed arylation of heterocycles through C-H bond activation with pivalic acid as a cocatalyst. | 2009 |
|
| Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation. | 2008-12-11 |
|
| Cross-coupling reactions of aryl pivalates with boronic acids. | 2008-11-05 |
|
| An expedient route to Montanine-type Amaryllidaceae alkaloids: total syntheses of (-)-brunsvigine and (-)-manthine. | 2008-10-03 |
|
| Enantioselective formation of ibuprofen-S-acyl-glutathione in vitro in incubations of ibuprofen with rat hepatocytes. | 2008-09 |
|
| Scanning tunneling microscopy study of black dye and deoxycholic acid adsorbed on a rutile TiO2(110). | 2008-08-05 |
|
| Intramolecular Pd(II)-catalyzed oxidative biaryl synthesis under air: reaction development and scope. | 2008-07-04 |
|
| Effectiveness of UV-based advanced oxidation processes for the remediation of hydrocarbon pollution in the groundwater: a laboratory investigation. | 2008-04-15 |
|
| Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation. | 2008-04-01 |
|
| Fluoxetine (Prozac) augments platelet activation mediated through protease-activated receptors. | 2008-04 |
|
| Au-catalyzed synthesis of (1Z,3E)-2-pivaloxy-1,3-dienes from propargylic pivalates. | 2008-03-26 |
|
| Ion-pair interaction in pyridinium carboxylate solutions. | 2008-02-07 |
|
| Protic ionic liquids: physicochemical properties and behavior as amphiphile self-assembly solvents. | 2008-01-24 |
|
| Mixed valence complexes involving MM quadruple bonds (M=Mo or W). | 2008-01-13 |
|
| Cross-coupling of aryl/alkenyl pivalates with organozinc reagents through nickel-catalyzed C-O bond activation under mild reaction conditions. | 2008 |
|
| Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment. | 2008 |
|
| Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias. | 2008 |
|
| Inhibitory purinergic transmission in mouse caecum: role for P2Y1 receptors as prejunctional modulators of ATP release. | 2007-12-12 |
|
| Toward a magnetostructural correlation for a family of Mn6 SMMs. | 2007-10-17 |
|
| Carnitine-associated encephalopathy caused by long-term treatment with an antibiotic containing pivalic acid. | 2007-09 |
|
| 5(6)-carboxyfluorescein revisited: new protecting group, separation of isomers, and their spectral properties on oligonucleotides. | 2007-08-19 |
|
| Tixocortol pivalate: what is the right concentration? | 2007-07 |
|
| Pivalate lowers litter sizes and weights in female rats independent of its effect on carnitine status. | 2007-07 |
|
| Investigating the mechanistic basis for hepatic toxicity induced by an experimental chemokine receptor 5 (CCR5) antagonist using a compendium of gene expression profiles. | 2007-06 |
|
| Conformational enantiomeric disorder in tripivaloylmethane. | 2007-06 |
|
| Evidence that ATP or a related purine is an excitatory neurotransmitter in the longitudinal muscle of mouse distal colon. | 2007-05 |
|
| Chromium-catalyzed arylmagnesiation of alkynes. | 2007-04-12 |
|
| Palladium-catalyzed benzene arylation: incorporation of catalytic pivalic acid as a proton shuttle and a key element in catalyst design. | 2006-12-27 |
|
| Studies of a molecular hourglass: synthesis and magnetic characterisation of a cyclic dodecanuclear {Cr10Cu2} complex. | 2006-11-06 |
|
| [Luliberin analogues exhibiting a cytotoxic effect on tumor cells in vitro]. | 2006-10-18 |
|
| Pyrones to pyrans: enantioselective radical additions to acyloxy pyrones. | 2006-10-18 |
|
| 1D helical polymeric chain with a pseudo-5(3) screw axis formed by cuprophilicity. synthesis and crystal structure of copper(I) pivalate. | 2006-09-18 |
|
| Induction of parturition in dairy cattle and its effects on health and subsequent lactation and reproductive performance. | 2006-09 |
|
| Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid. | 2006-08 |
|
| Antiplasmodial and antitrypanosomal activity of new esters and ethers of 4-dialkylaminobicyclo[2.2.2]octan-2-ols. | 2006-08 |
|
| Magnesium bistrifluoromethanesulfonimide as a new and efficient acylation catalyst. | 2006-07-21 |
|
| Synthesis, structure, and magnetic properties of (6-9)-nuclear Ni(II) trimethylacetates and their heterospin complexes with nitroxides. | 2006-07-10 |
|
| Synthesis, reactivities, and magnetostructural properties of FeIII, FeIII-O-FeIII, and ZnIIFeIII-O-FeIIIZnII complexes of a tetraiminodiphenolate macrocycle. | 2006-06-12 |
|
| Hypocarnitinaemia induced by sodium pivalate in the rat is associated with left ventricular dysfunction and impaired energy metabolism. | 2006 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:24:39 GMT 2025
by
admin
on
Mon Mar 31 21:24:39 GMT 2025
|
| Record UNII |
813RE8BX41
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
813RE8BX41
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
200-922-5
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
75-98-9
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
813RE8BX41
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
1426868
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | RxNorm | ||
|
C005566
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
65449
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
DTXSID8026432
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
PIVALIC ACID
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
m8895
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | Merck Index | ||
|
5211
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
100000138947
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
6417
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
SUB79491
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY | |||
|
45133
Created by
admin on Mon Mar 31 21:24:39 GMT 2025 , Edited by admin on Mon Mar 31 21:24:39 GMT 2025
|
PRIMARY |